Editor’s Letter

Published in:
Volume 3 / Year 2014 / Issue 4

Fourth and final issue of GaBI Journal’s third volume

Page: 161

The interest in the development, regulatory approval, use, and post-marketing surveillance of generic and biosimilar pharmaceutical products continues to increase; as illustrated by the tremendous number of views (over 1,028,324… Read More »

Go Back Print